KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aramark (ARMK) Capital Expenditures (2016 - 2026)

Aramark (ARMK) has disclosed Capital Expenditures for 14 consecutive years, with $122.2 million as the latest value for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 1.91% to $122.2 million in Q1 2026 year-over-year; TTM through Jan 2026 was $491.5 million, a 13.87% increase, with the full-year FY2025 number at $489.2 million, up 14.46% from a year prior.
  • Capital Expenditures was $122.2 million for Q1 2026 at Aramark, down from $142.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $142.2 million in Q4 2025 to a low of $51.8 million in Q3 2022.
  • A 5-year average of $103.8 million and a median of $105.3 million in 2022 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: plummeted 66.24% in 2022, then surged 141.17% in 2023.
  • Aramark's Capital Expenditures stood at $88.9 million in 2022, then surged by 30.05% to $115.6 million in 2023, then rose by 3.67% to $119.9 million in 2024, then rose by 18.64% to $142.2 million in 2025, then decreased by 14.1% to $122.2 million in 2026.
  • Per Business Quant, the three most recent readings for ARMK's Capital Expenditures are $122.2 million (Q1 2026), $142.2 million (Q4 2025), and $111.4 million (Q2 2025).